Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Regent Of The University Of Michigan is currently addressing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This prosecution activity involves a distinct examiner and a distinct art unit. The presence of only a pending matter suggests a focused phase of patent activity for this specific portfolio. This arrangement allows the university to concentrate its legal resources on a specific technical dialogue with the patent office.
VANHORN, ABIGAIL LOUISE serves as the busiest examiner for the company, with 1 pending office action under review. This action accounts for the total pending workload identified in the data. Prosecution strategy for the university in this area is currently tied to the findings of this individual examiner. By focusing on the specific precedents and preferences of this examiner, the university can more effectively navigate the path to allowance for this application. The involvement of a distinct examiner and a distinct art unit minimizes the complexity of managing multiple simultaneous prosecution timelines.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VANHORN, ABIGAIL LOUISE | 1 | 46.8% | +22.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18107779 | EFFICIENT AQUEOUS ENCAPSULATION AND CONTROLLED RELEASE OF BIOACTIVE AGENTS | VANHORN, ABIGAIL LOUISE | — |
| Art Unit | Apps |
|---|---|
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18107779 | EFFICIENT AQUEOUS ENCAPSULATION AND CONTROLLED RELEASE OF BIOACTIVE AGENTS | VANHORN, ABIGAIL LOUISE | 1636 | §103DP | Non-Final OA | — | Pending | Feb 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial